These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 15268662)

  • 1. Messenger RNA-based vaccines.
    Pascolo S
    Expert Opin Biol Ther; 2004 Aug; 4(8):1285-94. PubMed ID: 15268662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges and advances towards the rational design of mRNA vaccines.
    Pollard C; De Koker S; Saelens X; Vanham G; Grooten J
    Trends Mol Med; 2013 Dec; 19(12):705-13. PubMed ID: 24138818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The messenger's great message for vaccination.
    Pascolo S
    Expert Rev Vaccines; 2015 Feb; 14(2):153-6. PubMed ID: 25586101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ReNAissanCe of mRNA-based cancer therapy.
    Van Lint S; Renmans D; Broos K; Dewitte H; Lentacker I; Heirman C; Breckpot K; Thielemans K
    Expert Rev Vaccines; 2015 Feb; 14(2):235-51. PubMed ID: 25263094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Messenger RNA-based vaccines: progress, challenges, applications.
    Kramps T; Probst J
    Wiley Interdiscip Rev RNA; 2013; 4(6):737-49. PubMed ID: 23893949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic vaccination for the active immunotherapy of cancer.
    Bronte V
    Curr Gene Ther; 2001 May; 1(1):53-100. PubMed ID: 12109138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. mRNA vaccination with charge-altering releasable transporters elicits human T cell responses and cures established tumors in mice.
    Haabeth OAW; Blake TR; McKinlay CJ; Waymouth RM; Wender PA; Levy R
    Proc Natl Acad Sci U S A; 2018 Sep; 115(39):E9153-E9161. PubMed ID: 30201728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmid DNA- and messenger RNA-based anti-cancer vaccination.
    Weide B; Garbe C; Rammensee HG; Pascolo S
    Immunol Lett; 2008 Jan; 115(1):33-42. PubMed ID: 18006079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination with Messenger RNA: A Promising Alternative to DNA Vaccination.
    Tombácz I; Weissman D; Pardi N
    Methods Mol Biol; 2021; 2197():13-31. PubMed ID: 32827130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Messenger RNA-based vaccines with dual activity induce balanced TLR-7 dependent adaptive immune responses and provide antitumor activity.
    Fotin-Mleczek M; Duchardt KM; Lorenz C; Pfeiffer R; Ojkić-Zrna S; Probst J; Kallen KJ
    J Immunother; 2011 Jan; 34(1):1-15. PubMed ID: 21150709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor vaccination using messenger RNA: prospects of a future therapy.
    Kreiter S; Diken M; Selmi A; Türeci Ö; Sahin U
    Curr Opin Immunol; 2011 Jun; 23(3):399-406. PubMed ID: 21497074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical evaluation of mRNA trimannosylated lipopolyplexes as therapeutic cancer vaccines targeting dendritic cells.
    Le Moignic A; Malard V; Benvegnu T; Lemiègre L; Berchel M; Jaffrès PA; Baillou C; Delost M; Macedo R; Rochefort J; Lescaille G; Pichon C; Lemoine FM; Midoux P; Mateo V
    J Control Release; 2018 May; 278():110-121. PubMed ID: 29630987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. mRNA vaccines - a new era in vaccinology.
    Pardi N; Hogan MJ; Porter FW; Weissman D
    Nat Rev Drug Discov; 2018 Apr; 17(4):261-279. PubMed ID: 29326426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic mRNA delivery to leukocytes.
    Granot-Matok Y; Kon E; Dammes N; Mechtinger G; Peer D
    J Control Release; 2019 Jul; 305():165-175. PubMed ID: 31121277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA-based vaccination: sending a strong message.
    Weiner DB
    Mol Ther; 2013 Mar; 21(3):506-8. PubMed ID: 23449108
    [No Abstract]   [Full Text] [Related]  

  • 16. Lipopolyplex potentiates anti-tumor immunity of mRNA-based vaccination.
    Persano S; Guevara ML; Li Z; Mai J; Ferrari M; Pompa PP; Shen H
    Biomaterials; 2017 May; 125():81-89. PubMed ID: 28231510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of the first phase I/II clinical vaccination trial with direct injection of mRNA.
    Weide B; Carralot JP; Reese A; Scheel B; Eigentler TK; Hoerr I; Rammensee HG; Garbe C; Pascolo S
    J Immunother; 2008; 31(2):180-8. PubMed ID: 18481387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. mRNA transcript therapy.
    Weissman D
    Expert Rev Vaccines; 2015 Feb; 14(2):265-81. PubMed ID: 25359562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type I Interferons Interfere with the Capacity of mRNA Lipoplex Vaccines to Elicit Cytolytic T Cell Responses.
    De Beuckelaer A; Pollard C; Van Lint S; Roose K; Van Hoecke L; Naessens T; Udhayakumar VK; Smet M; Sanders N; Lienenklaus S; Saelens X; Weiss S; Vanham G; Grooten J; De Koker S
    Mol Ther; 2016 Nov; 24(11):2012-2020. PubMed ID: 27506450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA vaccines: a role for liposomes.
    Gregoriadis G
    Curr Opin Mol Ther; 1999 Feb; 1(1):39-42. PubMed ID: 11249682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.